CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
89.35
-0.44 (-0.49%)
At close: Nov 13, 2026, 4:00 PM EST
89.21
-0.14 (-0.16%)
After-hours: Nov 13, 2026, 7:58 PM EST
CVS Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 11,738 | 8,453 | 8,586 | 8,196 | 12,945 | 9,408 |
Short-Term Investments | 3,149 | 2,145 | 2,407 | 3,259 | 2,778 | 3,117 |
Cash & Short-Term Investments | 14,887 | 10,598 | 10,993 | 11,455 | 15,723 | 12,525 |
Cash Growth | 32.54% | -3.59% | -4.03% | -27.15% | 25.53% | 15.39% |
Accounts Receivable | 19,595 | 16,316 | 14,612 | 15,622 | 27,276 | 21,042 |
Other Receivables | 22,478 | 23,463 | 21,857 | 19,605 | - | 3,389 |
Receivables | 42,073 | 39,779 | 36,469 | 35,227 | 27,276 | 24,431 |
Inventory | 18,240 | 19,246 | 18,107 | 18,025 | 19,090 | 17,760 |
Restricted Cash | - | 59 | 95 | 90 | 144 | 3,065 |
Other Current Assets | 4,192 | 5,032 | 2,981 | 3,061 | 3,400 | 2,227 |
Total Current Assets | 79,392 | 74,714 | 68,645 | 67,858 | 65,633 | 60,008 |
Property, Plant & Equipment | 27,548 | 28,056 | 28,937 | 30,435 | 30,745 | 32,018 |
Long-Term Investments | 34,066 | 32,669 | 28,934 | 23,019 | 21,096 | 23,025 |
Goodwill | 85,478 | 85,478 | 91,272 | 91,272 | 78,150 | 79,121 |
Other Intangible Assets | 24,224 | 25,508 | 27,323 | 29,234 | 24,803 | 29,026 |
Other Long-Term Assets | 7,367 | 7,113 | 8,104 | 7,910 | 7,848 | 9,801 |
Total Assets | 258,075 | 253,538 | 253,215 | 249,728 | 228,275 | 232,999 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 17,875 | 17,641 | 15,892 | 14,897 | 14,838 | 12,544 |
Accrued Expenses | 42,645 | 37,724 | 35,730 | 35,415 | 28,816 | 26,391 |
Short-Term Debt | - | - | 2,119 | 200 | - | - |
Current Portion of Long-Term Debt | 3,457 | 4,007 | 3,559 | 2,706 | 1,719 | 4,155 |
Current Portion of Leases | 1,920 | 1,798 | 1,816 | 1,807 | 1,737 | 1,696 |
Current Unearned Revenue | - | 62 | 144 | 149 | 71 | 87 |
Other Current Liabilities | 27,200 | 27,460 | 25,349 | 24,015 | 22,240 | 22,934 |
Total Current Liabilities | 93,097 | 88,692 | 84,609 | 79,189 | 69,421 | 67,807 |
Long-Term Debt | 57,223 | 59,237 | 59,232 | 57,313 | 49,070 | 50,721 |
Long-Term Leases | 12,697 | 14,908 | 16,194 | 17,359 | 18,206 | 19,427 |
Pension & Post-Retirement Benefits | - | 165 | 169 | 189 | 197 | 250 |
Long-Term Deferred Tax Liabilities | 3,866 | 3,832 | 3,806 | 4,311 | 4,016 | 6,270 |
Other Long-Term Liabilities | 10,503 | 11,322 | 13,475 | 14,731 | 15,596 | 13,143 |
Total Liabilities | 177,386 | 178,156 | 177,485 | 173,092 | 156,506 | 157,618 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 18 | 18 | 18 | 18 | 18 | 17 |
Additional Paid-In Capital | 51,136 | 50,384 | 49,643 | 48,974 | 48,175 | 47,360 |
Retained Earnings | 66,707 | 61,196 | 62,837 | 61,604 | 56,398 | 54,906 |
Treasury Stock | -36,769 | -36,790 | -36,818 | -33,838 | -31,829 | -28,144 |
Comprehensive Income & Other | -595 | 406 | -120 | -297 | -1,293 | 936 |
Total Common Equity | 80,497 | 75,214 | 75,560 | 76,461 | 71,469 | 75,075 |
Minority Interest | 192 | 168 | 170 | 175 | 300 | 306 |
Shareholders' Equity | 80,689 | 75,382 | 75,730 | 76,636 | 71,769 | 75,381 |
Total Liabilities & Equity | 258,075 | 253,538 | 253,215 | 249,728 | 228,275 | 232,999 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 75,297 | 79,950 | 82,920 | 79,385 | 70,732 | 75,999 |
Net Cash (Debt) | -60,410 | -69,352 | -71,927 | -67,930 | -55,009 | -63,474 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -46.98 | -54.56 | -56.99 | -52.66 | -41.58 | -47.76 |
Filing Date Shares Outstanding | 1,279 | 1,272 | 1,261 | 1,258 | 1,284 | 1,313 |
Total Common Shares Outstanding | 1,280 | 1,271 | 1,260 | 1,288 | 1,300 | 1,322 |
Working Capital | -13,705 | -13,978 | -15,964 | -11,331 | -3,788 | -7,799 |
Book Value Per Share | 62.89 | 59.18 | 59.97 | 59.36 | 54.98 | 56.79 |
Tangible Book Value | -29,205 | -35,772 | -43,035 | -44,045 | -31,484 | -33,072 |
Tangible Book Value Per Share | -22.82 | -28.14 | -34.15 | -34.20 | -24.22 | -25.02 |
Land | - | 1,809 | 1,847 | 1,958 | 1,996 | 2,038 |
Buildings | - | 4,593 | 4,632 | 4,571 | 4,545 | 4,225 |
Machinery | - | 11,737 | 11,716 | 11,024 | 12,734 | 13,619 |
Leasehold Improvements | - | 6,812 | 6,725 | 6,511 | 6,238 | 6,242 |